Citation Impact
Citing Papers
Clinical guidelines on the management of hepatitis C
2001
Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study
1999
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
2000
Carcinogenicity of deoxycholate, a secondary bile acid
2011
The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria
2006
Barrett esophagus: histology and pathology for the clinician
2009
Long-Term Results of a Randomized Prospective Study Comparing Medical and Surgical Treatment of Barrett’s Esophagus
2003
Inflammation and cancer
2002 StandoutNature
A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.
2004
Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up
1999
Bile acids as carcinogens in human gastrointestinal cancers
2004
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Hepatitis C Virus Infection
2001 Standout
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results
2006
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography
2006
Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods
1999
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus
2004
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells
2010 StandoutNobel
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
2011 Standout
Cost-Effectiveness of Photodynamic Therapy for Treatment of Barrett's Esophagus with High Grade Dysplasia
2003
Management of Barrett's Esophagus: A National Study of Practice Patterns and Their Cost Implications
1999
Current status of ablative therapies in esophageal disorders
2001
Esophageal Cancer
2003 Standout
Detection of Barrett's Esophagus After Endoscopic Healing of Erosive Esophagitis
2006
Epidemiology of Non-Steroidal Anti-Inflammatory Drugs and Cancer
2003
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
1997
Treatment of Choledocholithiasis in Patients with Liver Cirrhosis Surgical Treatment or Endoscopic Sphincterotomy?
1993
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
Barrett Esophagus and Risk of Esophageal Cancer
2013
The Incidence of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Barrett's Esophagus Makes a Difference
2005
Occult Esophageal Adenocarcinoma
1999
Protective Immune Response to Hepatitis C Virus in Chimpanzees Rechallenged Following Clearance of Primary Infection
2001 StandoutNobel
Management of Hepatocellular Carcinoma *
2005 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
1995
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
The protocol for a european double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: The capp study
1995
Curative Resection for Esophageal Adenocarcinoma
2001
Differential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection
2001
Oesophageal carcinoma
2013 Standout
Dysplasia and Cancer in a Large Multicenter Cohort of Patients With Barrett’s Esophagus
2006
The Natural History of Hepatitis C Virus Infection
2000
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
1998 Standout
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
1995 Standout
Hereditary Colorectal Cancer
2003 Standout
Barrett's oesophagus
2009
Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention
2003
Long-Term Survival After Esophagectomy for Barrett's Adenocarcinoma in Endoscopically Surveyed and Nonsurveyed Patients
2002
Hereditary Gastrointestinal Polyposis and Nonpolyposis Syndromes
1994
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis
2002
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data
1999
Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer
2002
Complications of Endoscopic Biliary Sphincterotomy
1996 Standout
Systematic Four-Quadrant Biopsy Detects Barrett's Dysplasia in More Patients Than Nonsystematic Biopsy
2008
Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis
2003
Gut microbiota, metabolites and host immunity
2016 Standout
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Secondary Chemoprevention of Barrett's Esophagus With Celecoxib: Results of a Randomized Trial
2007
Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome
2000
Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia
2000
Immune Response to Epitopes of Hepatitis C Virus (HCV) Structural Proteins in HCV-Infected Humans and Chimpanzees
1996
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Mismatch Repair Deficiency in Phenotypically Normal Human Cells
1995 StandoutScienceNobel
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Polyamines and cancer: old molecules, new understanding
2004
Barrett's Esophagus
2002
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Gastroesophageal Reflux Disease: Prevalence, Clinical, Endoscopic and Histopathological Findings in 1,128 Consecutive Patients Referred for Endoscopy due to Dyspeptic and Reflux Symptoms
2000
Yield of Intestinal Metaplasia in Patients with Suspected Short-Segment Barrett's Esophagus (SSBE) on Repeat Endoscopy
2002
Visual Demonstration of Hepatitis C Virus–Specific Memory Cd8+ T–Cell Expansion in Patients With Acute Hepatitis C
2001
Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux
2007
Clinical and Demographic Predictors of Barrett's Esophagus Among Patients With Gastroesophageal Reflux Disease
2001
To C or not to C: these are the questions
1995
Gastroesophageal Reflux Disease
1996
Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C
2005 StandoutNobel
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Nonsteroidal Anti-Inflammatory Drugs and Cancer Prevention
2000
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Updated Guidelines for The Diagnosis and Treatment of Gastroesophageal Reflux Disease
1999
Randomized versus historical controls for clinical trials
1982
Nanoparticles in Photodynamic Therapy
2015 Standout
Red cell transfusion for the management of upper gastrointestinal haemorrhage
2010
Spermidine in health and disease
2018 StandoutScience
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus
1999 StandoutNobel
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies
2002 StandoutNobel
DNA Double-Strand Breaks
2002 StandoutNobel
Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
1999
Global cancer statistics, 2012
2015 Standout
Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients
1997 StandoutNobel
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of R E Sampliner being referenced
Correlation of oesophageal acid exposure with Barrett's oesophagus length
2001
Short Segment Barrett's Esophagus—The Need for Standardization of the Definition and of Endoscopic Criteria
1998
Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?
2000
Medical decision analysis of endoscopic surveillance of Barrett’s oesophagus to prevent oesophageal adenocarcinoma
2002
NSAID effect on sporadic colon polyps.
1993
Natural History of Cholelithiasis in Patients with Alcoholic Cirrhosis (Cholelithiasis in Cirrhotic Patients)
1987
Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium.
1997
Use of blood component therapy for gastrointestinal bleeding in patients with cirrhosis of the liver.
1975
Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine.
1994
The Natural History of Community-Acquired Hepatitis C in the United States
1993
Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
1997
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
1998
The role of laser ablation and photodynamic therapy
1995
Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
1993
Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk.
1996